Peoples


E. J. Kim, Ph.D.

Founder and Chief Executive Officer

Theracion biomedical Co., Ltd.

E. J. Kim has served as Chief Executive Officer of Theracion Biomedical since establishment of the company in June 2016. Mr. Kim has more than 20 years of experience in the medical device and pharmaceutical industry. Prior to establishing Theracion biomedical, he served as principal scientist at one of the major nonvascular stent/medical device company from 2010 to 2016. Before 2010, Mr. Kim worked for Celltrion Chemical Institute, Korea, which is currently Celltrion Pharm., one of the leading pharmaceutical manufacturers in Korea, serving as senior scientist for drug delivery system. Prior to joining Celltrion, he spent three years at Kwangdong Pharmaceuticals, Korea, in R&D center for studying various OTC/ETC and DDS, and 5 years at Samyang Biopharm., Korea, working in new medical technology and pharmaceuticals, such as the drug delivery system (DDS), and anticancer drugs, and biodegradable guided tissue regeneration membrane. Throughout his carrier, he has experienced R&D, RA and clinical trials in the field of medical device and pharmaceuticals.

Mr. Kim participated in graduate school of Chemical engineering, McMaster University, CANADA and received an Ph.D. in biomaterials from the department of polymer science and engineering at Kyungpook National University, Korea. 



Oh Hyeong Kwon, Ph.D.

Chief Technology Officer

Theracion biomedical Co., Ltd.

Professor

Department of Polymer Science and Engineering,

Kumoh National Institute of Technology(KNIT)

Professor Kwon has served as CTO, Theracion Biomedical since 2016. He is currently professor, the department of polymer science and engineering, at KNIT, Korea. Prior to joining KNIT, he received an Ph.D. from dept. of biomaterial chemistry, Kyoto University, Japan, in 1998. He has more than 25 years in biomaterial field and his research area includes topical hemostat, tissue engineering, biomedical nano fibers and intelligent polymer: thermo-, pH-, photo-sensitive polymers. 



Seong Yong Park, M.D., Ph.D.

Clinical Advisor

Theracion biomedical Co., Ltd.

Associate Professor

Department of Thoracic and Cardiovascular Surgery

Yonsei University College of Medicine, Korea

Dr. Park currently serves as associate professor, department of thoracic and cardiovascular surgery at Yonsei University College of Medicine, Korea. Dr. Park received M.D. and Ph.D. from Yonsei University College of Medicine, respectively. He joined as clinical advisor of Theracion Biomedical in 2021.

He is a member of the Korean Board of Thoracic and Cardiovascular Surgery and Korean Association for Thoracic and Cardiovascular Surgery member. 


International R&D Network


Motoichi Kurisawa, Ph.D.

Team leader and principal research scientist,

Nanomedicine and Biomaterials, Institute of

Bioengineering and Nanotechnology, Singapore

Motoichi Kurisawa received his Ph.D. degrees from the School of Materials Science, Japan Advanced Institute of Science and Technology (JAIST) in 1998. He conducted his postdoctoral experiences in the area of Drug Delivery Systems, Nanomedicine, Tissue engineering and Biomaterials and at Tokyo Women’s Medical University and Kyoto University. He joined Institute of Bioengineering and Nanotechnology (IBN) in 2003, and is currently Team Leader and Principal Research Scientist. For his scientific contribution, he was awarded outstanding paper award from Journal of Artificial Organ in 1997 and 2002. Based on the successful development of green tea catechin based-drug carrier, he also received the Grand Prize, The Crown Prince Creative, Innovative Product and Technical Advancement (CIPTA) Award in 2015 and First Prize in the ASEAN Category, The CIPTA Award in 2015. He serves on Editorial Boards of Biomedical Materials since 2016.